Countdown to IAS Pharma2024
  • days
  • hours
  • minutes
  • seconds
  • The IAS Pharma2020 Speakers:

    • Dr. Debo Odulana

      Dr. Debo Odulana

      Founder/CEO at Doctoora e-Health Limited

    Impact Africa Summit 2020: The Inaugural Edition

    Every day, healthcare experts and leaders in healthcare across the globe are innovating and changing the health and pharmaceutical sphere for the better. The IAS Pharma Inaugural awards & Gala Night, which would be presented annually gives an opportunity to recognize international and regional industry players, researchers, and innovators celebrating their outstanding IMPACT on research and development in reforming Africa’s healthcare.

    The gala night wis a forum for guests to make connections with industry experts, leaders, organizations, and peers who are driving research and innovation that is needed to shape the future of healthcare for Africa. It will also be a night to unwind with an exquisite repertoire of entertainment and a memorable dining experience.

    IAS Pharma2020 Partners

    Looking Ahead

    As we reflect on the resounding success of IAS 2020, we extend our gratitude to all participants, speakers, and sponsors who contributed to this transformative event. Your involvement has propelled us closer to a future of equitable healthcare innovation in Africa.

    Our Partners and Sponsors

    Meet some of our key note speakers from over the years, who have continually provided insights and perspectives on the latest industry development and sustainable healthcare reforms.

    Become an IAS Pharma Sponsor

    Get regular updates and hear the latest news and advancements from our team. Sign up for email updates.

    The IAS PHARMA 2024 is organized by Xcene Research, an African Contract Research Organization committed to providing clinical trials access to a more diverse population in Africa.

    Xcene Research Corporate Office

    1 Ogunsiji Close, S&B Tejuosho Estate, Allen Avenue Ikeja, Lagos Nigeria

    Connect With Us

    ©2024, Xcene Research. All Rights Reserved.